Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127729251 | 12772925 | 1 | I | 2009 | 20100203 | 20160922 | 20160922 | EXP | US-ASTRAZENECA-2016SF00525 | ASTRAZENECA | 0.19 | YR | M | Y | 0.00000 | 20160922 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127729251 | 12772925 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | UNKNOWN | 0 | 50 | MG | INJECTION | |||||
127729251 | 12772925 | 2 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | UNKNOWN | 0 | 100 | MG | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127729251 | 12772925 | 1 | Antiviral prophylaxis |
127729251 | 12772925 | 2 | Antiviral prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127729251 | 12772925 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127729251 | 12772925 | Apnoea | |
127729251 | 12772925 | Aspiration | |
127729251 | 12772925 | Bradycardia | |
127729251 | 12772925 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127729251 | 12772925 | 1 | 20090211 | 20090211 | 0 | |
127729251 | 12772925 | 2 | 20090311 | 20090311 | 0 |